STAGE II PANCREATIC CANCER AJCC V8
Clinical trials for STAGE II PANCREATIC CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II PANCREATIC CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II PANCREATIC CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sound waves could supercharge chemo against tough pancreatic cancer
Disease control OngoingThis study tests a new method called sonoporation, which uses ultrasound and tiny gas bubbles to help chemotherapy drugs get into cancer cells more effectively. About 120 adults with advanced pancreatic cancer will receive either standard chemotherapy alone or chemotherapy plus s…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Flemming Forsberg • Aim: Disease control
Last updated May 26, 2026 08:03 UTC
-
New drug cocktail takes aim at tough pancreatic cancer
Disease control OngoingThis early-phase study tests a new drug combination for people with advanced pancreatic cancer that has a specific marker (mesothelin). The treatment pairs a targeted chemotherapy (anetumab ravtansine) with immunotherapy drugs (nivolumab, ipilimumab) and/or standard chemo (gemcit…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New drug cocktail aims to starve pancreatic tumors
Disease control OngoingThis early-phase study tests a combination of two drugs—calaspargase pegol-mknl and cobimetinib—in people with advanced pancreatic cancer that has spread. The goal is to find the safest dose and see if the combo can control the disease by cutting off the cancer cells' food supply…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Personalized cell therapy trial for advanced cancers withdrawn before enrollment
Disease control TerminatedThis early-stage trial aimed to test the safety and effectiveness of STIL101, a personalized cell therapy made from a patient's own tumor-fighting T cells, for several advanced cancers including pancreatic, colorectal, kidney, cervical, and melanoma. The treatment involved collec…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New drug combo shows promise for Hard-to-Treat pancreatic cancer
Disease control OngoingThis study tests whether a combination of two drugs, lenvatinib and pembrolizumab, can help control advanced pancreatic cancer that cannot be removed by surgery. About 28 adults whose cancer has not worsened after initial treatment will receive these drugs as maintenance therapy.…
Matched conditions: STAGE II PANCREATIC CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC